Cancer Immunotherapy - Virotherapy : Dr. Zihai Li - Stem Cells Which "Fool Immune System"
User comments:
[2012-01-16 04:42:27] sn1pe352 - NOTE: ( ...
NOTE: (Immunotherapy Research) Dr. Cassian Yee, Drs. Zihai Li and Bei Liu,, Zheng Cui, Ph.D, William Coley, Victor Ambros, Gary Ruvkun, and David Baulcombee
[2012-01-15 16:15:50] sn1pe352 - Coley developed the ...Coley developed the theory that it was the infections which had helped patients in the past to recover from their cancer. So he began to treat patients by injecting a brew of Streptococcus pyogenes directly into inoperable tumors. The treatment was most effective when it provoked a fever and a full-blown infection. According to Stephen Hoption Cann of the University of British Columbia, "He had successes you simply couldn't hope for today, curing even extensive metastatic disease."
[2012-01-15 00:07:51] sn1pe352 - UConn Health Center ...UConn Health Center researchers have uncovered a way to potentially use human stem cells as a kind of vaccine against colon cancer. This discovery, led by experts in immunology, Drs. Zihai Li and Bei Liu, builds upon a century old theory that immunizing with embryonic materials may generate an anti-tumor response by "fooling" the immune system into believing that cancer cells are present. The finding potentially opens up a new paradigm for cancer vaccine research.
[2012-01-15 00:07:08] sn1pe352 - (RobertsReview, RI, ...(RobertsReview, RI, USA) -- Immune cells in some cancer patient recognize, attack, and kill cancer cells, leading to full patient recovery. Recently Steven Rosenberg at the National Cancer Institute isolated these cancer kiling T cells (tumor-infiltrating lymphocytes) in a patient who had successfully beaten melanoma. He then introduced genetic information from them via a harmless retrovirus into the T cells of patients suffering from active cases of potentially deadly melanoma.
[2012-01-14 13:45:21] sn1pe352 - November 13, 2007 ...November 13, 2007 presentation by Edgar Engleman for the Stanford School of Medicine Medcast lecture series. Edgar Engleman, MD, medical director of the Stanford Blood Center, discusses his research involving the use of a special type of white blood cell as a treatment for cancer. Engleman, who is also a professor of pathology at the Stanford School of Medicine, and his team of researchers have been interested in dendritic cells, or DCs, which can provoke an immune response in the body.
[2012-01-14 13:45:06] sn1pe352 - November 13, 2007 ...November 13, 2007 presentation by Edgar Engleman for the Stanford School of Medicine Medcast lecture series. Edgar Engleman, MD, medical director of the Stanford Blood Center, discusses his research involving the use of a special type of white blood cell as a treatment for cancer. Engleman, who is also a professor of pathology at the Stanford School of Medicine, and his team of researchers have been interested in dendritic cells, or DCs, which can provoke an immune response in the body.
[2012-01-14 13:25:58] sn1pe352 - "By using a probe ..."By using a probe to shine a light on the tumour, the antibodies at the right place in the body can be brought to life. Any antibodies in the rest of the body will remain dormant, meaning side effects can be minimised. The activated antibodies then cause immune cells in the blood called T-cells to attack the cancer." "Just a few minutes of the light therapy directed at the region of the tumour would activate the T-cells causing her body's own immune cells to attack the tumour."
[2012-01-14 13:22:51] sn1pe352 - UConn Health Center ...UConn Health Center researchers have uncovered a way to potentially use human stem cells as a kind of vaccine against colon cancer. This discovery, led by experts in immunology, Drs. Zihai Li and Bei Liu, builds upon a century old theory that immunizing with embryonic materials may generate an anti-tumor response by "fooling" the immune system into believing that cancer cells are present. The finding potentially opens up a new paradigm for cancer vaccine research.